Neuromuscular Disease News and Research

RSS
Walgreens, MDA team up to offer free seasonal flu shots

Walgreens, MDA team up to offer free seasonal flu shots

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

New application for understanding peripheral nervous system

New application for understanding peripheral nervous system

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

U.S. FDA approves generic Levaquin for treatment of bacterial infections

U.S. FDA approves generic Levaquin for treatment of bacterial infections

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Neuralstem to present HSSC Phase I trial data in amyotrophic lateral sclerosis at AAN meeting

Neuralstem to present HSSC Phase I trial data in amyotrophic lateral sclerosis at AAN meeting

Enzo Life Sciences introduces ELISA system to detect SMN protein

Enzo Life Sciences introduces ELISA system to detect SMN protein

Hospital for Special Care announces opening of comprehensive heart failure in-patient unit in Connecticut

Hospital for Special Care announces opening of comprehensive heart failure in-patient unit in Connecticut

MDA grants $13.5 million to support new research treatments for neuromuscular diseases

MDA grants $13.5 million to support new research treatments for neuromuscular diseases

Muscular Dystrophy Association awards 44 research grants totaling $13.5 million

Muscular Dystrophy Association awards 44 research grants totaling $13.5 million

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Research shows nestin regulates formation of neuromuscular junction

Research shows nestin regulates formation of neuromuscular junction

Genzyme to expand Geel facility to support growth of Myozyme and Lumizyme for Pompe disease

Genzyme to expand Geel facility to support growth of Myozyme and Lumizyme for Pompe disease

GSK and Prosensa commence GSK2402968 Phase III study in DMD

GSK and Prosensa commence GSK2402968 Phase III study in DMD

Acceleron recieves $1.5 million MDA grant for ACE-031 clinical study in Duchenne Muscular Dystrophy

Acceleron recieves $1.5 million MDA grant for ACE-031 clinical study in Duchenne Muscular Dystrophy

MDA awards Repligen $1.4M for research of new compound with therapeutic potential for SMA

MDA awards Repligen $1.4M for research of new compound with therapeutic potential for SMA

MDA supports Repligen with $1.4M grant for RG3039 Spinal Muscular Atrophy development program

MDA supports Repligen with $1.4M grant for RG3039 Spinal Muscular Atrophy development program

SBUMC to rename and dedicate ALS clinic as Christopher Pendergast ALS Center of Excellence

SBUMC to rename and dedicate ALS clinic as Christopher Pendergast ALS Center of Excellence